Cargando…
Hepatic steatosis in women with polycystic ovary syndrome
BACKGROUND: This multi-center, cross-sectional study intended to explore the prevalence and risk factors of nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) in patients with polycystic ovary syndrome (PCOS). METHODS: Patients who met the PCOS...
Autores principales: | Hong, Xinyu, Guo, Zaixin, Yu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521461/ https://www.ncbi.nlm.nih.gov/pubmed/37752440 http://dx.doi.org/10.1186/s12902-023-01456-6 |
Ejemplares similares
-
Prevalence of hepatic steatosis in women with polycystic ovary syndrome
por: Karoli, Ritu, et al.
Publicado: (2013) -
Predictors of response to ovulation induction using letrozole in women with polycystic ovary syndrome
por: Guo, Zaixin, et al.
Publicado: (2023) -
Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome
por: Chakraborty, Semanti, et al.
Publicado: (2020) -
Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome
por: Chen, Shuwen, et al.
Publicado: (2023) -
Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome
por: Jobira, Beza, et al.
Publicado: (2021)